Back to Search Start Over

Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARY

Authors :
Ladan Zand
Nattawat Klomjit
Source :
Kidney360
Publication Year :
2021
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects

Subjects :
Moderator Commentary
medicine.medical_specialty
Cyclophosphamide
business.industry
Urology
General Medicine
medicine.disease
Glomerulonephritis, Membranous
Membranous nephropathy
medicine
Humans
Rituximab
business
Immunosuppressive Agents
medicine.drug

Details

ISSN :
26417650
Volume :
2
Database :
OpenAIRE
Journal :
Kidney360
Accession number :
edsair.doi.dedup.....1d505b83e181c4500d270dba7596eb84
Full Text :
https://doi.org/10.34067/kid.0002492021
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details